Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
about
Genetic data and electronic health records: a discussion of ethical, logistical and technological considerationsPostal survey of physicians and laboratories: practices and perceptions of molecular oncology testingTwenty questions in genetic medicine--an assessment of World Wide Web databases for genetics information at the point of care.Improving identification of lynch syndrome patients: a comparison of research data with clinical records.Pilot study of pharmacist-assisted delivery of pharmacogenetic testing in a primary care setting.Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels.Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.Are public health professionals prepared for public health genomics? A cross-sectional survey in Italy.Survey on knowledge, attitudes, and training needs of Italian residents on genetic tests for hereditary breast and colorectal cancerPanel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory.Communication, encouragement, and cancer screening in families with and without mutations for hereditary nonpolyposis colorectal cancer: a pilot study.Risk information exposure and direct-to-consumer genetic testing for BRCA mutations among women with a personal or family history of breast or ovarian cancer.Familial testicular cancer: interest in genetic testing among high-risk family members.Physicians' current practices and opportunities for DNA banking of dying patients with cancerGenetic testing and cancer risk management recommendations by physicians for at-risk relatives.Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.Genomic risk profiling: attitudes and use in personal and clinical care of primary care physicians who offer risk profiling.Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers.Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia.Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of FloridaDelivery of Internet-based cancer genetic counselling services to patients' homes: a feasibility studyProfessional perspectives about pharmacogenetic testing and managing ancillary findingsValue of Genetic Testing for Hereditary Colorectal Cancer in a Probability-Based US Online SampleCancer risk assessment by rural and Appalachian family medicine physiciansModes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriersGenetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?Improving referral for genetic risk assessment in ovarian cancer using an electronic medical record system.Primary care physicians' knowledge of and experience with pharmacogenetic testingPatterns of cancer genetic testing: a randomized survey of Oregon clinicians.A systematic review of factors that act as barriers to patient referral to genetic servicesNon-genetic health professionals' attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancerA statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences.Public Health Approaches and Barriers to Educating Providers about Hereditary Breast and Ovarian Cancer Syndrome.BRCA1 and BRCA2 genetic testing-pitfalls and recommendations for managing variants of uncertain clinical significance.Guidelines for genetic risk assessment of hereditary breast and ovarian cancer: early disagreements and low utilizationPrimary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristicsCancer genetic counselor information needs for risk communication: a qualitative evaluation of interview transcripts.Too many referrals of low-risk women for BRCA1/2 genetic services by family physicians.
P2860
Q26830861-4ACB1942-E0EF-470B-A2CF-F45D82271354Q30227715-68E06619-7947-4BA1-8032-685917B2875AQ30483973-96FE9BDF-4322-4929-9523-18BC94E7DA97Q30580847-6FECF8DF-1413-4B2D-9D04-E00897D00393Q30612258-7237AE50-3C78-4BAB-B1DB-9BACC24914DCQ33422607-A48093A1-B26F-4684-BECE-429755A07DA2Q33703141-EAC4004F-3890-4243-8D71-93053EC48888Q33783281-9281F464-36F8-41D3-9610-6F9CE05694BDQ33891444-30802329-6398-4198-BCEC-8DFFE0299B3BQ34022144-432DA90A-299D-4828-BD90-89368339F415Q34051401-EAA1EA46-C884-4CC6-B2CE-4B5C18566301Q34235711-E63E3C16-5A07-4677-9C57-1DE0C3C32B02Q34573358-C821285F-CDEA-4E30-B05E-2B54462B4455Q34974920-9E4F6CF3-516C-4676-8B0A-1BE295D4151CQ34985909-109327A1-7EE9-4EC7-8A1E-5721D7A3897DQ35102571-A9B32C24-92AE-457F-8002-CBA807FB9767Q35113219-6F9817D2-24F5-4AD0-BE76-B05C11C88C7EQ35163789-31FC1EDE-2B9D-4313-9809-C2F38C9153D3Q35194662-EAA9EE77-FA72-43B7-B075-2842139E8F82Q35375003-8CACF863-DE25-4C4D-95C3-E95C6306DE7FQ35686808-BDCEAA8D-7915-488E-8F03-85BEEC7895BDQ35693724-92C6E4F5-BADA-435D-887F-C6C7A056C0E8Q35850612-7CD218EB-E956-4C90-909A-D5D7AC9886F3Q35871974-E85B642B-5E18-4292-A91D-8921E28F09F4Q35900421-E193AD9E-A23A-4043-BACC-3E358D68B50CQ36108520-C494AC1D-E692-4B5F-8C4B-F2DE059D5969Q36110947-95EF0221-119D-4F0E-818F-C01B687561E8Q36130577-DDCFE235-0C3A-46F1-9430-AD0F95984A55Q36230218-4B759E2D-2BA5-47E5-A2BB-264DF119AC95Q36362526-16A94F69-1110-4199-A322-EE3734E4EDA9Q36695162-985164E5-F096-4010-9EC7-A06EA1C94062Q36717823-1AC6657D-420B-4E12-BCE9-A91829427AC8Q36789430-7E961885-C897-4E10-A7CA-B16689E002BFQ37010546-94A847C9-334D-4108-8FC6-F0A516E549AAQ37069363-242E7A31-7856-4B96-8C82-AAA4BE679E6BQ37220433-67BBC44D-BE93-4BEE-8897-2B554EED39A0Q37225176-459C699C-5515-45D7-9FE6-4014E7E0456FQ37270506-57917FF1-E10A-40F3-B671-E764563C599CQ37398700-9CDC57B6-E0F1-4B10-BE65-9A89FBDCD047Q37409287-651E51FF-2F82-434F-A00D-ABE8CFC51C44
P2860
Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Hereditary breast/ovarian and ...... ional sample of US physicians.
@ast
Hereditary breast/ovarian and ...... ional sample of US physicians.
@en
type
label
Hereditary breast/ovarian and ...... ional sample of US physicians.
@ast
Hereditary breast/ovarian and ...... ional sample of US physicians.
@en
prefLabel
Hereditary breast/ovarian and ...... ional sample of US physicians.
@ast
Hereditary breast/ovarian and ...... ional sample of US physicians.
@en
P2093
P2860
P356
P1476
Hereditary breast/ovarian and ...... ional sample of US physicians.
@en
P2093
A N Freedman
L Wideroff
M H Greene
S T Vadaparampil
P2860
P304
P356
10.1136/JMG.2004.030296
P407
P577
2005-03-22T00:00:00Z